Hepatic Encephalopathy Drugs Market, Global Outlook and Forecast 2022-2028
Hepatic encephalopathy (HE) is a severe complication of TIPS treatment in patients with cirrhosis and variceal bleeding. Lactulose, is considered the first-line therapeutic agent for treating hepatic encephalopathy. Based on route of administration, Hepatic Encephalopathy Drugs include oral (tablets & solutions) and injections.
This report contains market size and forecasts of Hepatic Encephalopathy Drugs in global, including the following market information:
Global Hepatic Encephalopathy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatic Encephalopathy Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Hepatic Encephalopathy Drugs companies in 2021 (%)
The global Hepatic Encephalopathy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatic Encephalopathy Drugs include ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health, Ferring Pharmaceuticals, Mallinckrodt, Umecrine Cognition, Norgine, Lupin and Kaleido Biosciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatic Encephalopathy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatic Encephalopathy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Hepatic Encephalopathy Drugs Market Segment Percentages, by Type, 2021 (%)
Global Hepatic Encephalopathy Drugs Market Segment Percentages, by Application, 2021 (%)
Global Hepatic Encephalopathy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Hepatic Encephalopathy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatic Encephalopathy Drugs revenues share in global market, 2021 (%)
Key companies Hepatic Encephalopathy Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Hepatic Encephalopathy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Hepatic Encephalopathy Drugs in global, including the following market information:
Global Hepatic Encephalopathy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatic Encephalopathy Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Hepatic Encephalopathy Drugs companies in 2021 (%)
The global Hepatic Encephalopathy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatic Encephalopathy Drugs include ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health, Ferring Pharmaceuticals, Mallinckrodt, Umecrine Cognition, Norgine, Lupin and Kaleido Biosciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatic Encephalopathy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatic Encephalopathy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Hepatic Encephalopathy Drugs Market Segment Percentages, by Type, 2021 (%)
- Injection
- Oral
Global Hepatic Encephalopathy Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Hepatic Encephalopathy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Hepatic Encephalopathy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatic Encephalopathy Drugs revenues share in global market, 2021 (%)
Key companies Hepatic Encephalopathy Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Hepatic Encephalopathy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- ASKA Pharmaceutical
- Cosmo Pharmaceuticals
- Bausch Health
- Ferring Pharmaceuticals
- Mallinckrodt
- Umecrine Cognition
- Norgine
- Lupin
- Kaleido Biosciences
- Kannalife Sciences
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Hepatic Encephalopathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatic Encephalopathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS OVERALL MARKET SIZE
2.1 Global Hepatic Encephalopathy Drugs Market Size: 2021 VS 2028
2.2 Global Hepatic Encephalopathy Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hepatic Encephalopathy Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Hepatic Encephalopathy Drugs Players in Global Market
3.2 Top Global Hepatic Encephalopathy Drugs Companies Ranked by Revenue
3.3 Global Hepatic Encephalopathy Drugs Revenue by Companies
3.4 Global Hepatic Encephalopathy Drugs Sales by Companies
3.5 Global Hepatic Encephalopathy Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hepatic Encephalopathy Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hepatic Encephalopathy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hepatic Encephalopathy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Hepatic Encephalopathy Drugs Market Size Markets, 2021 & 2028
4.1.2 Injection
4.1.3 Oral
4.2 By Type - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
4.2.1 By Type - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Hepatic Encephalopathy Drugs Sales & Forecasts
4.3.1 By Type - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
4.3.2 By Type - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
4.3.3 By Type - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Hepatic Encephalopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hepatic Encephalopathy Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
5.2.1 By Application - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Hepatic Encephalopathy Drugs Sales & Forecasts
5.3.1 By Application - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
5.3.2 By Application - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
5.3.3 By Application - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Hepatic Encephalopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Hepatic Encephalopathy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
6.2.1 By Region - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Hepatic Encephalopathy Drugs Sales & Forecasts
6.3.1 By Region - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
6.3.2 By Region - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
6.3.3 By Region - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.4.2 By Country - North America Hepatic Encephalopathy Drugs Sales, 2017-2028
6.4.3 US Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.4.4 Canada Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.4.5 Mexico Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Hepatic Encephalopathy Drugs Sales, 2017-2028
6.5.3 Germany Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.4 France Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.5 U.K. Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.6 Italy Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.7 Russia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.9 Benelux Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Hepatic Encephalopathy Drugs Sales, 2017-2028
6.6.3 China Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.4 Japan Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.5 South Korea Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.7 India Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.7.2 By Country - South America Hepatic Encephalopathy Drugs Sales, 2017-2028
6.7.3 Brazil Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.7.4 Argentina Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, 2017-2028
6.8.3 Turkey Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.4 Israel Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.6 UAE Hepatic Encephalopathy Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 ASKA Pharmaceutical
7.1.1 ASKA Pharmaceutical Corporate Summary
7.1.2 ASKA Pharmaceutical Business Overview
7.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Major Product Offerings
7.1.4 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.1.5 ASKA Pharmaceutical Key News
7.2 Cosmo Pharmaceuticals
7.2.1 Cosmo Pharmaceuticals Corporate Summary
7.2.2 Cosmo Pharmaceuticals Business Overview
7.2.3 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Major Product Offerings
7.2.4 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Cosmo Pharmaceuticals Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Hepatic Encephalopathy Drugs Major Product Offerings
7.3.4 Bausch Health Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Bausch Health Key News
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Corporate Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Major Product Offerings
7.4.4 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Ferring Pharmaceuticals Key News
7.5 Mallinckrodt
7.5.1 Mallinckrodt Corporate Summary
7.5.2 Mallinckrodt Business Overview
7.5.3 Mallinckrodt Hepatic Encephalopathy Drugs Major Product Offerings
7.5.4 Mallinckrodt Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Mallinckrodt Key News
7.6 Umecrine Cognition
7.6.1 Umecrine Cognition Corporate Summary
7.6.2 Umecrine Cognition Business Overview
7.6.3 Umecrine Cognition Hepatic Encephalopathy Drugs Major Product Offerings
7.6.4 Umecrine Cognition Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Umecrine Cognition Key News
7.7 Norgine
7.7.1 Norgine Corporate Summary
7.7.2 Norgine Business Overview
7.7.3 Norgine Hepatic Encephalopathy Drugs Major Product Offerings
7.7.4 Norgine Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Norgine Key News
7.8 Lupin
7.8.1 Lupin Corporate Summary
7.8.2 Lupin Business Overview
7.8.3 Lupin Hepatic Encephalopathy Drugs Major Product Offerings
7.8.4 Lupin Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Lupin Key News
7.9 Kaleido Biosciences
7.9.1 Kaleido Biosciences Corporate Summary
7.9.2 Kaleido Biosciences Business Overview
7.9.3 Kaleido Biosciences Hepatic Encephalopathy Drugs Major Product Offerings
7.9.4 Kaleido Biosciences Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Kaleido Biosciences Key News
7.10 Kannalife Sciences
7.10.1 Kannalife Sciences Corporate Summary
7.10.2 Kannalife Sciences Business Overview
7.10.3 Kannalife Sciences Hepatic Encephalopathy Drugs Major Product Offerings
7.10.4 Kannalife Sciences Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Kannalife Sciences Key News
8 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Hepatic Encephalopathy Drugs Production Capacity, 2017-2028
8.2 Hepatic Encephalopathy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatic Encephalopathy Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HEPATIC ENCEPHALOPATHY DRUGS SUPPLY CHAIN ANALYSIS
10.1 Hepatic Encephalopathy Drugs Industry Value Chain
10.2 Hepatic Encephalopathy Drugs Upstream Market
10.3 Hepatic Encephalopathy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatic Encephalopathy Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Hepatic Encephalopathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatic Encephalopathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS OVERALL MARKET SIZE
2.1 Global Hepatic Encephalopathy Drugs Market Size: 2021 VS 2028
2.2 Global Hepatic Encephalopathy Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hepatic Encephalopathy Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Hepatic Encephalopathy Drugs Players in Global Market
3.2 Top Global Hepatic Encephalopathy Drugs Companies Ranked by Revenue
3.3 Global Hepatic Encephalopathy Drugs Revenue by Companies
3.4 Global Hepatic Encephalopathy Drugs Sales by Companies
3.5 Global Hepatic Encephalopathy Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hepatic Encephalopathy Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hepatic Encephalopathy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hepatic Encephalopathy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Hepatic Encephalopathy Drugs Market Size Markets, 2021 & 2028
4.1.2 Injection
4.1.3 Oral
4.2 By Type - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
4.2.1 By Type - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Hepatic Encephalopathy Drugs Sales & Forecasts
4.3.1 By Type - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
4.3.2 By Type - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
4.3.3 By Type - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Hepatic Encephalopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hepatic Encephalopathy Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
5.2.1 By Application - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Hepatic Encephalopathy Drugs Sales & Forecasts
5.3.1 By Application - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
5.3.2 By Application - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
5.3.3 By Application - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Hepatic Encephalopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Hepatic Encephalopathy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hepatic Encephalopathy Drugs Revenue & Forecasts
6.2.1 By Region - Global Hepatic Encephalopathy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Hepatic Encephalopathy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Hepatic Encephalopathy Drugs Sales & Forecasts
6.3.1 By Region - Global Hepatic Encephalopathy Drugs Sales, 2017-2022
6.3.2 By Region - Global Hepatic Encephalopathy Drugs Sales, 2023-2028
6.3.3 By Region - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.4.2 By Country - North America Hepatic Encephalopathy Drugs Sales, 2017-2028
6.4.3 US Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.4.4 Canada Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.4.5 Mexico Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Hepatic Encephalopathy Drugs Sales, 2017-2028
6.5.3 Germany Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.4 France Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.5 U.K. Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.6 Italy Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.7 Russia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.5.9 Benelux Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Hepatic Encephalopathy Drugs Sales, 2017-2028
6.6.3 China Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.4 Japan Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.5 South Korea Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.6.7 India Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.7.2 By Country - South America Hepatic Encephalopathy Drugs Sales, 2017-2028
6.7.3 Brazil Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.7.4 Argentina Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, 2017-2028
6.8.3 Turkey Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.4 Israel Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Hepatic Encephalopathy Drugs Market Size, 2017-2028
6.8.6 UAE Hepatic Encephalopathy Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 ASKA Pharmaceutical
7.1.1 ASKA Pharmaceutical Corporate Summary
7.1.2 ASKA Pharmaceutical Business Overview
7.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Major Product Offerings
7.1.4 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.1.5 ASKA Pharmaceutical Key News
7.2 Cosmo Pharmaceuticals
7.2.1 Cosmo Pharmaceuticals Corporate Summary
7.2.2 Cosmo Pharmaceuticals Business Overview
7.2.3 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Major Product Offerings
7.2.4 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Cosmo Pharmaceuticals Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Hepatic Encephalopathy Drugs Major Product Offerings
7.3.4 Bausch Health Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Bausch Health Key News
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Corporate Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Major Product Offerings
7.4.4 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Ferring Pharmaceuticals Key News
7.5 Mallinckrodt
7.5.1 Mallinckrodt Corporate Summary
7.5.2 Mallinckrodt Business Overview
7.5.3 Mallinckrodt Hepatic Encephalopathy Drugs Major Product Offerings
7.5.4 Mallinckrodt Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Mallinckrodt Key News
7.6 Umecrine Cognition
7.6.1 Umecrine Cognition Corporate Summary
7.6.2 Umecrine Cognition Business Overview
7.6.3 Umecrine Cognition Hepatic Encephalopathy Drugs Major Product Offerings
7.6.4 Umecrine Cognition Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Umecrine Cognition Key News
7.7 Norgine
7.7.1 Norgine Corporate Summary
7.7.2 Norgine Business Overview
7.7.3 Norgine Hepatic Encephalopathy Drugs Major Product Offerings
7.7.4 Norgine Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Norgine Key News
7.8 Lupin
7.8.1 Lupin Corporate Summary
7.8.2 Lupin Business Overview
7.8.3 Lupin Hepatic Encephalopathy Drugs Major Product Offerings
7.8.4 Lupin Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Lupin Key News
7.9 Kaleido Biosciences
7.9.1 Kaleido Biosciences Corporate Summary
7.9.2 Kaleido Biosciences Business Overview
7.9.3 Kaleido Biosciences Hepatic Encephalopathy Drugs Major Product Offerings
7.9.4 Kaleido Biosciences Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Kaleido Biosciences Key News
7.10 Kannalife Sciences
7.10.1 Kannalife Sciences Corporate Summary
7.10.2 Kannalife Sciences Business Overview
7.10.3 Kannalife Sciences Hepatic Encephalopathy Drugs Major Product Offerings
7.10.4 Kannalife Sciences Hepatic Encephalopathy Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Kannalife Sciences Key News
8 GLOBAL HEPATIC ENCEPHALOPATHY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Hepatic Encephalopathy Drugs Production Capacity, 2017-2028
8.2 Hepatic Encephalopathy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatic Encephalopathy Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HEPATIC ENCEPHALOPATHY DRUGS SUPPLY CHAIN ANALYSIS
10.1 Hepatic Encephalopathy Drugs Industry Value Chain
10.2 Hepatic Encephalopathy Drugs Upstream Market
10.3 Hepatic Encephalopathy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatic Encephalopathy Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Hepatic Encephalopathy Drugs in Global Market
Table 2. Top Hepatic Encephalopathy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hepatic Encephalopathy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hepatic Encephalopathy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Hepatic Encephalopathy Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Hepatic Encephalopathy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hepatic Encephalopathy Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Hepatic Encephalopathy Drugs Product Type
Table 9. List of Global Tier 1 Hepatic Encephalopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 46. ASKA Pharmaceutical Corporate Summary
Table 47. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offerings
Table 48. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Cosmo Pharmaceuticals Corporate Summary
Table 50. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offerings
Table 51. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Bausch Health Corporate Summary
Table 53. Bausch Health Hepatic Encephalopathy Drugs Product Offerings
Table 54. Bausch Health Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Ferring Pharmaceuticals Corporate Summary
Table 56. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offerings
Table 57. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Mallinckrodt Corporate Summary
Table 59. Mallinckrodt Hepatic Encephalopathy Drugs Product Offerings
Table 60. Mallinckrodt Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Umecrine Cognition Corporate Summary
Table 62. Umecrine Cognition Hepatic Encephalopathy Drugs Product Offerings
Table 63. Umecrine Cognition Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Norgine Corporate Summary
Table 65. Norgine Hepatic Encephalopathy Drugs Product Offerings
Table 66. Norgine Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Lupin Corporate Summary
Table 68. Lupin Hepatic Encephalopathy Drugs Product Offerings
Table 69. Lupin Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Kaleido Biosciences Corporate Summary
Table 71. Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offerings
Table 72. Kaleido Biosciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Kannalife Sciences Corporate Summary
Table 74. Kannalife Sciences Hepatic Encephalopathy Drugs Product Offerings
Table 75. Kannalife Sciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Hepatic Encephalopathy Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 77. Global Hepatic Encephalopathy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Hepatic Encephalopathy Drugs Production by Region, 2017-2022 (MT)
Table 79. Global Hepatic Encephalopathy Drugs Production by Region, 2023-2028 (MT)
Table 80. Hepatic Encephalopathy Drugs Market Opportunities & Trends in Global Market
Table 81. Hepatic Encephalopathy Drugs Market Drivers in Global Market
Table 82. Hepatic Encephalopathy Drugs Market Restraints in Global Market
Table 83. Hepatic Encephalopathy Drugs Raw Materials
Table 84. Hepatic Encephalopathy Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Hepatic Encephalopathy Drugs Downstream
Table 86. Hepatic Encephalopathy Drugs Downstream Clients in Global Market
Table 87. Hepatic Encephalopathy Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Hepatic Encephalopathy Drugs in Global Market
Table 2. Top Hepatic Encephalopathy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hepatic Encephalopathy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hepatic Encephalopathy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Hepatic Encephalopathy Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Hepatic Encephalopathy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hepatic Encephalopathy Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Hepatic Encephalopathy Drugs Product Type
Table 9. List of Global Tier 1 Hepatic Encephalopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hepatic Encephalopathy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hepatic Encephalopathy Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Hepatic Encephalopathy Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales, (MT), 2023-2028
Table 46. ASKA Pharmaceutical Corporate Summary
Table 47. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product Offerings
Table 48. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Cosmo Pharmaceuticals Corporate Summary
Table 50. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product Offerings
Table 51. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Bausch Health Corporate Summary
Table 53. Bausch Health Hepatic Encephalopathy Drugs Product Offerings
Table 54. Bausch Health Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Ferring Pharmaceuticals Corporate Summary
Table 56. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product Offerings
Table 57. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Mallinckrodt Corporate Summary
Table 59. Mallinckrodt Hepatic Encephalopathy Drugs Product Offerings
Table 60. Mallinckrodt Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Umecrine Cognition Corporate Summary
Table 62. Umecrine Cognition Hepatic Encephalopathy Drugs Product Offerings
Table 63. Umecrine Cognition Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Norgine Corporate Summary
Table 65. Norgine Hepatic Encephalopathy Drugs Product Offerings
Table 66. Norgine Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Lupin Corporate Summary
Table 68. Lupin Hepatic Encephalopathy Drugs Product Offerings
Table 69. Lupin Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Kaleido Biosciences Corporate Summary
Table 71. Kaleido Biosciences Hepatic Encephalopathy Drugs Product Offerings
Table 72. Kaleido Biosciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Kannalife Sciences Corporate Summary
Table 74. Kannalife Sciences Hepatic Encephalopathy Drugs Product Offerings
Table 75. Kannalife Sciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Hepatic Encephalopathy Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 77. Global Hepatic Encephalopathy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Hepatic Encephalopathy Drugs Production by Region, 2017-2022 (MT)
Table 79. Global Hepatic Encephalopathy Drugs Production by Region, 2023-2028 (MT)
Table 80. Hepatic Encephalopathy Drugs Market Opportunities & Trends in Global Market
Table 81. Hepatic Encephalopathy Drugs Market Drivers in Global Market
Table 82. Hepatic Encephalopathy Drugs Market Restraints in Global Market
Table 83. Hepatic Encephalopathy Drugs Raw Materials
Table 84. Hepatic Encephalopathy Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Hepatic Encephalopathy Drugs Downstream
Table 86. Hepatic Encephalopathy Drugs Downstream Clients in Global Market
Table 87. Hepatic Encephalopathy Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Hepatic Encephalopathy Drugs Segment by Type
Figure 2. Hepatic Encephalopathy Drugs Segment by Application
Figure 3. Global Hepatic Encephalopathy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatic Encephalopathy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatic Encephalopathy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Hepatic Encephalopathy Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Hepatic Encephalopathy Drugs Revenue in 2021
Figure 9. By Type - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hepatic Encephalopathy Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hepatic Encephalopathy Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 19. US Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 33. China Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hepatic Encephalopathy Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Hepatic Encephalopathy Drugs by Region, 2021 VS 2028
Figure 50. Hepatic Encephalopathy Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Hepatic Encephalopathy Drugs Segment by Type
Figure 2. Hepatic Encephalopathy Drugs Segment by Application
Figure 3. Global Hepatic Encephalopathy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatic Encephalopathy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatic Encephalopathy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Hepatic Encephalopathy Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Hepatic Encephalopathy Drugs Revenue in 2021
Figure 9. By Type - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hepatic Encephalopathy Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hepatic Encephalopathy Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 19. US Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 33. China Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hepatic Encephalopathy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hepatic Encephalopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hepatic Encephalopathy Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Hepatic Encephalopathy Drugs by Region, 2021 VS 2028
Figure 50. Hepatic Encephalopathy Drugs Industry Value Chain
Figure 51. Marketing Channels
